Hollencrest Capital Management decreased its holdings in shares of Atomera Inc (NASDAQ:ATOM) by 2.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 551,186 shares of the technology company’s stock after selling 13,750 shares during the quarter. Hollencrest Capital Management owned 3.23% of Atomera worth $1,698,000 at the end of the most recent quarter.
Separately, BlackRock Inc. raised its stake in Atomera by 93.8% during the second quarter. BlackRock Inc. now owns 68,155 shares of the technology company’s stock worth $343,000 after acquiring an additional 32,986 shares in the last quarter. 20.74% of the stock is currently owned by institutional investors.
Shares of NASDAQ ATOM opened at $4.32 on Friday. The stock has a 50-day moving average price of $3.35 and a two-hundred day moving average price of $3.75. Atomera Inc has a 12 month low of $2.46 and a 12 month high of $5.84. The company has a market cap of $73.59 million, a price-to-earnings ratio of -4.85 and a beta of 0.76.
Several research analysts have commented on the company. Zacks Investment Research downgraded Atomera from a “buy” rating to a “hold” rating in a research note on Tuesday, December 31st. ValuEngine downgraded Atomera from a “buy” rating to a “hold” rating in a research note on Friday, January 10th.
Atomera Incorporated engages in developing, commercializing, and licensing proprietary materials, processes, and technologies for the semiconductor industry primarily in Europe and the Asia Pacific. The company's lead technology is Mears Silicon Technology, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors.
Further Reading: How prevalent are 12b-1 fees?
Want to see what other hedge funds are holding ATOM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atomera Inc (NASDAQ:ATOM).
Receive News & Ratings for Atomera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atomera and related companies with MarketBeat.com's FREE daily email newsletter.